The prostate, part of the male reproductive system, is a gland located under the bladder and in front of the rectum. Prostate cancer usually begins in the gland cells and grows slowly, so many men have prostate cancer but are unaware of it. Sometimes, however, prostate cancer will grow and spread quickly. Prostate cancer is highly curable when detected and treated early.
Unfortunately, many men with prostate cancer become confused regarding the complex array of options that are available for prevention and treatment. The Prostate Cancer and Genitourinary Oncology Program at The James can help men and their families choose among the array of prostate cancer treatment options.
Most important, our treatment team offers a multidisciplinary approach with specialists in medical oncology, radiation therapy and urology providing integrated and coordinated multimodality care for prostate cancer. Your physician will discuss these prostate cancer treatment options with you, as appropriate:
Expectant therapy – “watchful waiting"
In addition, The James is a cutting-edge research facility where discovery is translated into more effective prevention and diagnostic strategies as well as more effective and safer treatments. Among recent research advances:
- The James was one of many sites in a national study involving 18,000 men that demonstrated the ability of a hormonal agent, finasteride, to reduce the risk of prostate cancer by 25 percent. More than 250 men in Ohio and Kentucky participated through the Ohio State clinics directed by Steven K. Clinton, MD, PhD, and Robert Bahnson, MD. The study was the first in history to demonstrate that an intervention could protect men from developing prostate cancer.
- The James is participating in the largest prostate cancer prevention trial to date, called SELECT (Selenium and Vitamin E Cancer Prevention Trial). The Ohio State effort, directed by J. Paul Monk, MD, and Drs. Clinton and Bahnson, will determine whether dietary supplements of vitamin E and selenium can prevent prostate cancer. The 12-year study is expected to involve more than 400 trial sites, with approximately 32,000 healthy men over the age of 55 (over 50 for African-Americans) participating.
- Dr. Clinton and colleagues at the OSUCCC – James are seeking to prove whether consumption of tomato-based products and soy can reduce the risk of prostate cancer, as epidemiologic studies have suggested. These investigators are bringing dietary and nutritional studies into the clinic, where men with prostate cancer are able to participate in these important and exciting clinical trials. Read more...
This section of the Web site will give you access to:
If you have questions about prostate cancer, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and holidays).View The James' prostate cancer fact sheet.
Additional information is available in the National Comprehensive Cancer Network's Prostate Cancer Treatment Guidelines for Patients.